Source:http://linkedlifedata.com/resource/pubmed/id/18604473
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-10-2
|
pubmed:abstractText |
Central nervous system (CNS) germinoma is a curable tumor and its recurrence rate after initial therapy may be approximately 10% or higher. This study elucidates the time-course of recurrence and results of salvage therapy. Twenty-five patients with recurrent germinoma treated at Hokkaido University Hospital were retrospectively reviewed. The median age at initial treatment was 12 years (range: 8-37). All patients had been tumor-free for at least 6 months after the initial treatment. The median follow-up period was 134 months (range: 44-338). The median age at first recurrence was 18 years and the median time to the first recurrence was 50 months. Among the patients, 9 (36%) had the first recurrence at 60 months or later. The latest recurrence in a patient occurred 230 months after the initial treatment. The results of salvage therapy were estimated in all 25 patients. Seventeen patients (68%) were salvaged and were tumor-free at the final observation. The remaining 8 patients died of disease. At first recurrence, 11 patients were treated using radiation therapy with or without surgery and 7 out of the 11 patients died due to the recurrent tumor. On the other hand, 13 patients who received salvage chemotherapy and radiotherapy were tumor-free at the last follow-up. In conclusion, late recurrence is not a rare event in patients with CNS germinoma. To identify a true cure rate of this disease, a 10-year or longer observation period may be required. As a salvage therapy, platinum-based chemotherapy followed by wide-field low-dose radiation therapy appears to be effective.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0167-594X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-11
|
pubmed:meshHeading |
pubmed-meshheading:18604473-Adolescent,
pubmed-meshheading:18604473-Adult,
pubmed-meshheading:18604473-Central Nervous System Neoplasms,
pubmed-meshheading:18604473-Child,
pubmed-meshheading:18604473-Female,
pubmed-meshheading:18604473-Follow-Up Studies,
pubmed-meshheading:18604473-Germinoma,
pubmed-meshheading:18604473-Humans,
pubmed-meshheading:18604473-Male,
pubmed-meshheading:18604473-Recurrence,
pubmed-meshheading:18604473-Remission Induction,
pubmed-meshheading:18604473-Retrospective Studies,
pubmed-meshheading:18604473-Salvage Therapy,
pubmed-meshheading:18604473-Time Factors,
pubmed-meshheading:18604473-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
Late recurrence and salvage therapy of CNS germinomas.
|
pubmed:affiliation |
Department of Neurosurgery, Hokkaido University Hospital, North-15, West-7, Kita-ku, Sapporo 060-8638, Japan. kamoshima2002@yahoo.co.jp
|
pubmed:publicationType |
Journal Article
|